FIELD: biotechnology, medicine.
SUBSTANCE: invention relates to vaccine composition useful in prophylaxis and treatment of hepatitis C and/or hepatitis B virus infections. Claimed composition contains DNA which expresses protein variant containing E1 regions of HCV antigen and capsid protein of HCV or HBV, wherein one of composition components acts as adjuvant of another one.
EFFECT: improved vaccine composition.
7 cl, 9 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINAL COMPOSITION AGAINST HEPATITIS C VIRUS | 2005 |
|
RU2351363C2 |
| PHARMACEUTICAL COMPOSITIONS FOR THERAPEUTIC APPLICATION | 2004 |
|
RU2362586C2 |
| CHEMERICAL ANTIGENES FOR VACCINE AGAINST HEPATITIS C VIRUS | 2013 |
|
RU2639504C2 |
| RECOMBINANT VECTORS BASED ON 'LIVE' VIRUS OF FOWL POX AND THEIR APPLICATION IN PHARMACEUTICAL COMPOSITIONS AGAINST VIRUS OF HEPATITIS C | 2005 |
|
RU2353651C2 |
| AGENTS AND METHODS OF TREATING HEPATITIS B VIRUS | 2017 |
|
RU2740802C2 |
| METHOD FOR PRODUCTION OF ANTIGEN AGGREGATES AND USES THEREOF IN PHARMACEUTICALS | 2001 |
|
RU2266754C2 |
| POLYNUCLEOTIDE SEQUENCE CODING STRUCTURED PERTACTIN PROTEIN; VECTOR INCLUDING SUCH SEQUENCE; AND VACCINE COMPOSITIONS CONTAINING PERTACTIN PROTEIN OR VECTOR | 2008 |
|
RU2499046C2 |
| RECOMBINANT MODIFIED VIRUS OF VACCINE ANKARA ABLE TO EXPRESS HEPATITIS C VIRUS STRUCTURAL ANTIGENS | 2002 |
|
RU2270860C2 |
| RECOMBINANT PLASMIDE DNA pU8HBc-preS1, ENCODING PROTEIN GENE OF HEPATITIS B VIRUS CORE ANTIGEN INCLUDING pre-S1 REGION EPITOPE OF HEPATITIS B VIRUS SURFACE PROTEIN AND BACTERIUM STRAIN Escherichia coli AR PRODUCER OF HYBRID HBc-preS1 PROTEIN | 2005 |
|
RU2295570C2 |
| AGENTS AND METHODS BASED ON USING FIBRONECTIN OF DOMAIN EDA | 2006 |
|
RU2430738C2 |
